An investigation of clinical features of HBsAg and anti-HBs positive patients with chronic hepatitis B

Song JinYun; Wang JianFang; Wu XuPing; Huang Ling

doi:10.3969/j.issn.1001-5256.2016.11.016

Issue 11

Nov. 2016

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2016 > 32(11): 2092-2095

PDF( 1565 KB)

An investigation of clinical features of HBsAg and anti-HBs positive patients with chronic hepatitis B

DOI: 10.3969/j.issn.1001-5256.2016.11.016

Published Date: 2016-11-20

Abstract

Abstract

Objective To investigate the phenomenon of coexistence of HBsAg and anti- HBs and its clinical features,as well as related causes. Methods A total of 2260 persons who underwent physical examination in The Second Affiliated Hospital of Southeast University from February 2011 to February 2014 were enrolled,among whom 830 were diagnosed with chronic hepatitis B. Chemiluminescence microparticle immunoassay was used to screen out 188 patients with coexistence of HBsAg and anti- HBs,and these patients were divided into HBeAg positive group( 101 patients) and HBeAg negative group( 87 patients). Another 200 patients with positive HBsAg and negative anti-HBs were enrolled as controls,among whom 80 were in the HBeAg- positive group and 120 were in the HBeAg- negative group. HBV serological markers,liver function,and viral load were measured and analyzed with reference to clinical manifestations. The chi- square test was used for comparison of categorical data between groups. Results There were five patterns of HBV serological markers in patients with positive HBsAg and anti- HBs,among which positive HBsAg,anti- HBs,HBeAg,and anti- HBc and negative anti- HBe were the most common and accounted for 47. 9%( 90 /188). The overall abnormal rate of liver function parameters was 69. 1%( 130 /188),and the positive rate of HBV DNA was 56. 9%( 107 /188). The two groups with positive HBeAg had a high level of HBV DNA replication,and there was no significant difference in the positive rate of HBV DNA between positive HBsAg and anti- HBs group and control group( P > 0. 05).In the groups with negative HBeAg,there was a significant difference in the proportion of patients with HBV DNA quantitation of > 1 × 105 IU / ml between positive HBsAg and anti- HBs group and control group( P < 0. 05). The sequencing of the S region of HBV showed that among the 80 patients with positive HBsAg and anti- HBs,27 had variations in this region,and the mutation rate reached 33. 7%. The major variation sites in S region included P29 L,S61L,P62 L,I126T / S,Q129 N,M133K,F134 L,G145R / K,L175 S,and L186 H. Conclusion The patients with positive HBsA g and anti- HBs account for a certain proportion in patients with hepatitis B,and the major reason may be variation of viral strains. This situation does not indicate the improvement in disease,and the appearance of anti- HBs may not achieve complete and effective HBsA g clearance. There may be persistent replication of viral DNA,which needs to be taken seriously.
- hepatitis B virus,
- hepatitis B surface antigens,
- hepatitis B antibodies,
- antigenic variation

FullText(HTML)

References(20)

References

[1]MONTINERI A,NIGRO L,LA ROSA R,et al.Treatment induced seroconversion to HBs Ab following HBV reactivation in the imnounosuppressed haematology and oncology patient:a clinical survey of 5 cases in Catania,Italy[J].J Clin Virol,2011,52(4):284-287.

[2]WANG HB,YU HB.An analysis of neutralization reaction in samples with positive anti-HBs and HBsAg[J].J Jilin Med Coll,2013,34(3):183-184.(in Chinese)王海波,于红博.抗-HBs和HBsAg同时阳性样本中和反应分析[J].吉林医药学院学报,2013,34(3):183-184.

[3]ZHANG XN.An explanation of the coexistence of HBsAg and anti-HBs[J].Chin J Exp Clin Infect Dis:Electronic Edition,2009,3(3):334-337.(in Chinese)张晓宁.HBsAg与抗-HBs共存现象的解释[J].中华实验和临床感染病杂志,2009,3(3):334-337.

[4]SAYAN M,SENTURK O,AKHAN SC,et al.Monitoring of hepatitis B virus surface antigen escape mutations and concomitantly nucleos(t)ide analog resistance mutations in Turkish patients with chronic hepatitis B[J].Int J Infect Dis,2010,14(Suppl 3):136-141.

[5]LIU W,HU T,WANG X,et al.Coexistence of hepatitis B surface antigen and anti-HBs in Chinese chronic hepatitis B virus patients relating to genotype C and mutations in the S and P gene reverse transcriptase region[J].Arch Virol,2012,157(4):627-634.

[6]LEE BS,CHO YK,JEONG SH,et al.Nationwide seroepidemiology of hepatitis B virus infection in South Korea in 2009emphasizes the coexistenceof HBsAg and anti-HBs[J].J Med Virol,2013,85(8):1327-1333.

[7]REN MX,MENG QH.Research progress in mechanism of coexistence of HBsAg and HBs Ab in patients with HBV infection[J].J Clin Hepatol,2014,30(4):375-378.(in Chinese)任美欣,孟庆华.HBV感染者HBsAg和抗-HBs双阳性发生机制[J].临床肝胆病杂志,2014,30(4):375-378.

[8]DING F,MIAO XL,LI YX,et al.Mutations in the S gene and in the overlapping reverse transcriptase region in chronic hepatitis B Chinese patients with coexistence of HBsA g and anti-HBs[J].Braz J Infect Dis,2016,20(1):1-7.

[9]LIU Y,ZHANG L,ZHOU JY,et al.Clinical and virological characteristics of chronic hepatitis B patients with coexistence of HBsAg and Anti-HBs[J].PLoS One,2016,11(1):e0146980.

[10]WANG ZG,DENG ZY,GUO JW,et al.Primary research of hepatitis B virus infected patients serum with HBsA g and antiHBs double positive[J].Int J Lab Med,2011,32(13):1456-1457.(in Chinese)王珍光,邓芝云,郭建巍,等.乙型肝炎病毒表面抗原与表面抗体同时阳性的血清学模式初步研究[J].国际检验医学杂志,2011,32(13):1456-1457.

[11]LIN QQ,LIU YC,LIU X.An experimental analysis of positive HBsAg and anti-HBs in measurement of HBsAg,antiHBs,HBeA g,anti-HBe,and anti-HBc levels[J].Lab Med Clin,2013,10(3):332-333.(in Chinese)林青青,刘远程,刘欣.两对半定量检测中HBsAg和抗-HBs同时阳性的实验分析[J].检验医学与临床,2013,10(3):332-333.

[12]JIANG L,CHEN CH,PU XK.Clinical significance of serological pattern and HBV DNA load in patients with positive HBsAg and anti-HBs[J].Curr Physician,2016,22(17):44-45.(in Chinese)蒋莉,陈春华,濮翔科.分析HBsAg和抗-HBs双阳患者血清模式与HBV DNA载量的临床定义[J].当代医学,2016,22(17):44-45.

[13]DING F,YU HG,LI YX,et al.Sequence analysis of the HBV S protein in Chinese patients with coexisting HBsA g and anti-HBs antibodies[J].J Med Virol,2015,87(12):2067-2073.

[14]INOUE J,KONDO Y,WAKUI Y,et al.Reactivation of resolved hepatitis B virus infection with immune escape mutations after long-term corticosteroid therapy[J].Clin J Gastroenterol,2016,9(2):93-98.

[15]LEE KM,KIM YS,KO YY,et al.Emergence of vaccine-induced escape of hepatitis B virus with multiple surface gene mutations in a Korean child[J].J Korean Med Sci,2001,16(3):359-362.

[16]ZHOU ZJ,LEI HB,LONG C.A preliminary analysis of positive serum HBsAg and anti-HBs[J].Int J Lab Med,2012,33(4):497-498.(in Chinese)周正菊,雷鸿斌,龙聪.血清HBsAg、抗-HBs双阳性结果的初步分析[J].国际检验医学杂志,2012,33(4):497-498.

[17]XIE SD,LIU CY,WANG WM,et al.Effect of different concurrence modes of anti-HBs with HBsAg on the effection status heptatitis B viruses[J].Chin J Gastroenterol Hepatol,2006,15(3):244-248.(in Chinese)谢士达,刘成永,王伟民,等.抗-HBs和HBsAg共存的不同模式对乙型肝炎病毒感染的影响[J].胃肠病学和肝病学杂志,2006,15(3):244-248.

[18]MIMMS L.Hepatitis B virus escape mutants:pushing the envelope of chronic hepatitis B virus infection[J].Hepatology,1995,21(3):884-887.

[19]KOHNO H,INOUE T,TSUDA F,et al.Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B[J].J Gen Virol,1996,77(8):1825-1831.

[20]SEO SI,CHOI HS,CHOI BY,et al.Coexistence of hepatitis B surface antigen and antibody to hepatitis B surface may increase the risk of hepatocellular carcinoma in chronic hepatitis B virus infection:a retrospective cohort study[J].J Med Virol,2014,86(1):124-130.

Relative Articles

[1]	Zhiru WANG, Wenjing ZHAO, Xi CHEN. Effect and mechanism of gallic acid on the proliferation， migration， invasion， and apoptosis of human hepatocellular carcinoma HepG2 cells[J]. Journal of Clinical Hepatology, 2025, 41(3): 493-498. doi: 10.12449/JCH250315
[2]	Junzhe CAI, Songbai LIU, Xiaobin FEI, Peng LIU, Changhao ZHU, Xing WANG, Yaozhen PAN. Effect of ankyrin-repeat domain-containing protein 22 on human hepatoma cells and its mechanism[J]. Journal of Clinical Hepatology, 2024, 40(5): 989-996. doi: 10.12449/JCH240519
[3]	Lina BAI, Ying LIU, Chunxiao TANG, Hongxin PIAO, Zhenhua LIN, Wanshan YANG, Aihua JIN. Mechanism of carrimycin in regulating the biological function of pancreatic cancer cells[J]. Journal of Clinical Hepatology, 2022, 38(12): 2793-2801. doi: 10.3969/j.issn.1001-5256.2022.12.020
[4]	Jianan ZHAO, Jinghua PENG, Ping LIU, Yiyang HU. Effect of Cordyceps polysaccharides on hepatocyte apoptosis induced by tumor necrosis factor-α[J]. Journal of Clinical Hepatology, 2021, 37(6): 1368-1372. doi: 10.3969/j.issn.1001-5256.2021.06.029
[5]	Lu Qian, Cheng Xin, Xia ZhenGuo, Chen Zhong. Effect of proteasome subunit beta type 4 on the proliferation and viability of human liver cancer SMMC7721 cells[J]. Journal of Clinical Hepatology, 2020, 36(3): 592-595. doi: 10.3969/j.issn.1001-5256.2020.03.024
[6]	Wang ZeXin, Guan LiJun, Li JianMing, Wang ZhiChao, Xue MengRuo, Qin XiaoJun. Effect of targeted regulation of the Wnt2 gene by microRNA( microRNA-21) on the proliferation and migration of HepG2 hepatoma cells[J]. Journal of Clinical Hepatology, 2020, 36(4): 803-807. doi: 10.3969/j.issn.1001-5256.2020.04.019
[7]	Xiao ErHui, Ning HuiBin, Kang YueHua, Yin Hui, Ma Li, Mao ZhongShan, Zhao Yan, Shang Jia. Downregulation of miR-196b in regulating the growth and apoptosis of hepatoma cells by targeting nuclear apoptosis-inducing factor 1[J]. Journal of Clinical Hepatology, 2020, 36(10): 2230-2235. doi: 10.3969/j.issn.1001-5256.2020.10.014
[8]	Zhang Yang, Chen ShuYing, Xu GuangRu. Effect of extracellular ubiquitin on the proliferation,invasion,and migration of hepatoma cells[J]. Journal of Clinical Hepatology, 2020, 36(6): 1289-1292. doi: 10.3969/j.issn.1001-5256.2020.06.020
[9]	Zhu YueKun, Zhao XianQi, Wang DaWei, Zhang Wei, Tian MaoLin, Li ZhengTian, Zhao Long, Li Chao, Jiang HongChi. Effect of cyclooxygenase-2 antisense RNA combined with celecoxib on the proliferation and apoptosis of hepatoma cells[J]. Journal of Clinical Hepatology, 2018, 34(12): 2614-2618. doi: 10.3969/j.issn.1001-5256.2018.12.021
[10]	Li YingYing, Zhan LiFen, Ceng ZheChao, Xu Shen. Effect of lobaplatin on proliferation and apoptosis of hepatocellular carcinoma HepG2 cells and related mechanism of action[J]. Journal of Clinical Hepatology, 2018, 34(4): 784-788. doi: 10.3969/j.issn.1001-5256.2018.04.018
[11]	Sha Liang, He JianBo, Li KeZhi, Chen Chuang, Huang Shan, Zhao YinNong, Lian Fang, Wu GuoBin. Influence of specific down-regulation of LKB1 expression on invasion and migration of hepatoma cells[J]. Journal of Clinical Hepatology, 2017, 33(5): 875-879. doi: 10.3969/j.issn.1001-5256.2017.05.016
[12]	Geng YaJun, Li ShuDong, Liu ShenZheng, Ren JianJun, Zhang Tong. Inhibitory effect of microRNA-149-5p in the proliferation and migration of HepG2 and Bel-7402 hepatoma cells[J]. Journal of Clinical Hepatology, 2017, 33(6): 1126-1130. doi: 10.3969/j.issn.1001-5256.2017.06.022
[13]	Zhang ChaoYa, Zhao XiangXuan, Lu ZaiMing, Guo QiYong. Research advances in sorafenib- induced apoptotic signaling pathways in liver cancer cells[J]. Journal of Clinical Hepatology, 2016, 32(4): 816-820. doi: 10.3969/j.issn.1001-5256.2016.04.048
[14]	Pan LiuLan, Jia ShengNan, Ma JingTing, Tai JingHua, Jin ZhenJing. Effect of decoy receptor 3 gene on hepatocyte apoptosis[J]. Journal of Clinical Hepatology, 2016, 32(7): 1330-1333. doi: 10.3969/j.issn.1001-5256.2016.07.023
[15]	Du SenRong, Mao XiaoRong, Xiao Ping, Chen Hong. Effects of PARP-1 inhibitors AG-014699 and AZD2281 on proliferation and apoptosis of human hepatoma cell line HepG2[J]. Journal of Clinical Hepatology, 2015, 31(6): 943-946. doi: 10.3969/j.issn.1001-5256.2015.06.027
[16]	Xu Li, Ma KeXin, Dong Bing, Liu HaiWang, Liu QinLong, Gao ZhenMing, Sun DeGuang, Zhang RiXin, Wang HaiBo, Wang LiMing, Liang Rui. Regulatory effect of miRNAs on apoptosis, migration, and cell cycle of hepatocellular carcinoma cells[J]. Journal of Clinical Hepatology, 2013, 29(7): 554-557.
[17]	Shen Bo, Nie YuQiang. Peroxisome proliferator- activated receptor gamma inhibits liver cancer proliferation and metastasis in vitro[J]. Journal of Clinical Hepatology, 2013, 29(9): 702-706. doi: 10.3969/j.issn.1001-5256.2013.09.018
[18]	Jia XiaoLi, Shi JuanJuan, Feng Ting, Cheng YanAn, Wang Rui, Liu JingKun, Dang ShuangSuo. Effects of guggulsterone on proliferation and apoptosis of HepG2 human hepatocellular carcinoma cells[J]. Journal of Clinical Hepatology, 2013, 29(6): 452-455.
[19]	Tai BoJun, Yao Min, Gu Xing, Shi Yun, Yu DanDan, Chen Jie, Zheng WenJie, Yao DengFu, Lu ShaoLin. Effects of silencing glypican- 3 gene transcription on proliferation and apoptosis of hepatoma cells[J]. Journal of Clinical Hepatology, 2013, 29(11): 863-866. doi: 10.3969/j.issn.1001-5256.2013.10.015
[20]	Qiao ChunPing, Chen YueXiang. Advances in study of the relationship between apoptosis and alcoholic liver disease[J]. Journal of Clinical Hepatology, 2012, 28(5): 386-390.

Supplements(0)

Cited By

Cited by

Periodical cited type(7)

1.	李慧萍，郑雪琴，赵群，唐建江. Ⅲ型前胶原、Ⅳ型胶原、层黏连蛋白和透明质酸酶在诊断肝纤维化程度中的应用. 检验医学与临床. 2019(05): 666-668 .
2.	吴一鸣，高树兴，殷新光. 核素首次通过法测定肝动脉血流指数预测日本血吸虫病肝纤维化程度?. 中国肝脏病杂志(电子版). 2018(02): 49-54 .
3.	柯叶芳，高国生，朱喆，陈必成. 血清腺苷脱氨酶对慢性HBV感染者显著肝纤维化的诊断价值. 临床肝胆病杂志. 2018(04): 760-763 . 本站查看
4.	吴一鸣，高树兴，殷新光. 测定肝动脉血流指数预测血吸虫肝纤维化的临床研究. 世界华人消化杂志. 2018(07): 434-440 .
5.	胡烨，张国. 肝纤维化诊断及其严重程度评估. 实用肝脏病杂志. 2017(01): 13-16 .
6.	王娉娉，杨芬. 生物组织弹性成像方法及其新技术进展. 激光生物学报. 2016(06): 501-508+514 .
7.	牟文倩，李春艳，陈延平. 继发性血色病1例报告. 临床肝胆病杂志. 2016(09): 1789-1790 . 本站查看

Other cited types(4)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (3548) PDF downloads(511)

An investigation of clinical features of HBsAg and anti-HBs positive patients with chronic hepatitis B

DOI: 10.3969/j.issn.1001-5256.2016.11.016